TY - JOUR
T1 - How much did it cost to develop and implement an eHealth intervention for a minority children population that overlapped with the COVID-19 pandemic
AU - Monashefsky, Alexandra
AU - Alon, Dar
AU - Baranowski, Tom
AU - Barreira, Tiago V.
AU - Chiu, Kelly A.
AU - Fleischman, Amy
AU - Green, Melanie C.
AU - Huang, Shirley
AU - Samuels, Ronald C.
AU - Sousa, Caio Victor
AU - Thompson, Debbe
AU - Lu, Amy S.
N1 - Funding Information:
The authors would like to thank Drs. I-Min Lee, Sarah Lessard, Lynne L. Levitsky, and Farzad Noubary for their helpful comments on this draft. The authors would like to thank Aleksandra Baran, Rashmi Borah, Romina Cabrera-Perez, Kelly Lee, Emma McGarrity, Harshita Menon, Aika Misawa, Grace Novoa, Kyung Jin Sun, and Neha Swaminathan for their effort in data collection. This project was supported in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK109316) and Northeastern University's Interdisciplinary Research Sabbatical. The study involving human participants was reviewed and approved by the Northeastern University Institutional Review Board (IRB) (IRB# 16-01-17). All children participants assented and their parents consented to participate in the study.
Funding Information:
The authors would like to thank Drs. I-Min Lee, Sarah Lessard, Lynne L. Levitsky, and Farzad Noubary for their helpful comments on this draft. The authors would like to thank Aleksandra Baran, Rashmi Borah, Romina Cabrera-Perez, Kelly Lee, Emma McGarrity, Harshita Menon, Aika Misawa, Grace Novoa, Kyung Jin Sun, and Neha Swaminathan for their effort in data collection. This project was supported in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases ( R01DK109316 ) and Northeastern University's Interdisciplinary Research Sabbatical. The study involving human participants was reviewed and approved by the Northeastern University Institutional Review Board (IRB) (IRB# 16-01-17). All children participants assented and their parents consented to participate in the study.
Publisher Copyright:
© 2022 The Authors
PY - 2023/2
Y1 - 2023/2
N2 - Background: eHealth interventions using active video games (AVGs) offer an alternative method to help children exercise, especially during a pandemic where options are limited. There is limited data on costs associated with developing and implementing such interventions. Objectives: We quantified the costs of delivering an eHealth RCT intervention among minority children during COVID-19. Methods: We categorized the total trial cost into five subcategories: intervention material development, advertising and recruitment, intervention delivery, personnel salaries, and COVID-19-related equipment costs. Results: The total RCT cost was $1,927,807 (Direct: $1,227,903; Indirect: $699,904) with three visits required for each participant. The average cost per participant completing the RCT (79 participants/237 visits) was $24,403 (Direct: $15,543; Indirect: $8860). Due to no-shows and cancellations (198 visits) and dropouts before study completion (61 visits; 56 participants), 496 visits had to be scheduled to ensure complete data collection on 79 participants. If all 496 visits were from participants completing the three-visit protocol, that would correspond to 165 participants, bringing the average cost per participant down to $11,684 (Direct: $7442; Indirect: $4242). Of the subcategories, intervention material development accounted for the largest portion, followed by personnel salaries. While the direct COVID-19-specific cost constituted <1% of the entire budget, the indirect effects were much larger and significantly impacted the trial. Conclusion: RCTs typically involve significant resources, even more so during a pandemic. Future eHealth intervention investigators should budget and plan accordingly to prepare for unexpected costs such as recruitment challenges to increase flexibility while maximizing the intervention efficacy.
AB - Background: eHealth interventions using active video games (AVGs) offer an alternative method to help children exercise, especially during a pandemic where options are limited. There is limited data on costs associated with developing and implementing such interventions. Objectives: We quantified the costs of delivering an eHealth RCT intervention among minority children during COVID-19. Methods: We categorized the total trial cost into five subcategories: intervention material development, advertising and recruitment, intervention delivery, personnel salaries, and COVID-19-related equipment costs. Results: The total RCT cost was $1,927,807 (Direct: $1,227,903; Indirect: $699,904) with three visits required for each participant. The average cost per participant completing the RCT (79 participants/237 visits) was $24,403 (Direct: $15,543; Indirect: $8860). Due to no-shows and cancellations (198 visits) and dropouts before study completion (61 visits; 56 participants), 496 visits had to be scheduled to ensure complete data collection on 79 participants. If all 496 visits were from participants completing the three-visit protocol, that would correspond to 165 participants, bringing the average cost per participant down to $11,684 (Direct: $7442; Indirect: $4242). Of the subcategories, intervention material development accounted for the largest portion, followed by personnel salaries. While the direct COVID-19-specific cost constituted <1% of the entire budget, the indirect effects were much larger and significantly impacted the trial. Conclusion: RCTs typically involve significant resources, even more so during a pandemic. Future eHealth intervention investigators should budget and plan accordingly to prepare for unexpected costs such as recruitment challenges to increase flexibility while maximizing the intervention efficacy.
KW - Active video game
KW - Budget planning
KW - Child obesity
KW - Exergame
KW - Intervention cost
KW - Physical activity
UR - http://www.scopus.com/inward/record.url?scp=85144076104&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85144076104&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2022.107044
DO - 10.1016/j.cct.2022.107044
M3 - Article
C2 - 36473682
AN - SCOPUS:85144076104
SN - 1551-7144
VL - 125
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
M1 - 107044
ER -